NCT04196114

Brief Summary

The STIMO-2 study aims to investigate TESS-supported rehabilitation training in sub-acute spinal cord injury (\< 6 months post-injury). The primary endpoint of this study is to assess the safety and feasibility of TESS. The preliminary effectiveness of the therapy is the secondary study endpoint. The mobility recovery status of patients, who undergo TESS-supported rehabilitation, will be assessed at 12 months post SCI, compared to their predicted recovery expectations based on standard rehabilitation program

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 12, 2019

Completed
2.1 years until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

1.2 years

First QC Date

December 5, 2019

Last Update Submit

October 4, 2023

Conditions

Keywords

spinal cord injury

Outcome Measures

Primary Outcomes (2)

  • Safety Measure: occurence of Serious Adverse Event

    Occurrence of Serious Adverse Event that are deemed related or possibly related to study procedure or to study investigational system

    Through study completion, until 12 months after injury

  • Feasibility Measure: use of TESS stimulation (in minutes) for improved mobility

    Measure of the absolute and relative usage of TESS (in minutes) during mobility rehabilitation sessions.

    Through study completion, until 12 months after injury

Secondary Outcomes (2)

  • Preliminary effectiveness: assessment of function recovery of leg motor function using the 6 mnWT distance

    Through study completion, until 12 months after injury

  • Preliminary effectiveness: mobility assessment using SCIM-III mobility score

    Through study completion, until 12 months after injury

Study Arms (1)

All patients

EXPERIMENTAL

All patients implanted.

Device: STIMO-2 device implantation

Interventions

Implantation of SCS lead in epidural space and implantation of neurostimulator in abdominal region

All patients

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient enrolled in the EMSCI study
  • Age 18 to 70 years old included
  • Focal spinal cord injury due to trauma
  • Patient with history of SCI within the past 6 months (sub-acute SCI)
  • Vertebral lesion T11 or above
  • Psychological condition compatible with study participation
  • Able and willing to fulfil all study procedures

You may not qualify if:

  • Severe or chronic medical disorder pre-existing SCI affecting rehabilitation
  • Active implanted device such as a pacemaker, implantable cardiac defibrillator
  • Inability to follow study procedures, e.g. due to language problems, psychological disorders, dementia
  • Pregnant or breast feeding
  • Participation in other interventional study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHUV

Lausanne, Canton of Vaud, 1011, Switzerland

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Coordinating investigator

Study Record Dates

First Submitted

December 5, 2019

First Posted

December 12, 2019

Study Start

February 1, 2022

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

October 5, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations